Last updated on: 05/08/2020
Name of organisation
1) Department/Research groupDepartment of Ageing and Chronic Diseases, Pharmacoepidemiologic Research Group,
2) Organisation/affiliationNorwegian Institute of Public Health
Short Name in the inventoryNIPH
Administrative Contact
Title Dr
Last name Furu
First name Kari
Address line 1P.O.Box 222 Skøyen
Address line 2
Address line 3
CityOSLO
PostcodeNO-0213
CountryNorway
Phone number (incl. country code)4721078185
Alternative phone number4795221824
Fax number (incl. country code)
Scientific Contact
Title Dr
Last name Furu
First name Kari
Address line 1P.O.Box 222 Skøyen
Address line 2
Address line 3
CityOSLO
PostcodeNO-0213
CountryNorway
Phone number (incl. country code)4721078185
Alternative phone number4795221824
Fax number (incl. country code)
Alternative Scientific Contact
Title Dr
Last name Karlstad
First name Øystein
Address line 1P.O.Box 222 Skøyen
Address line 2
Address line 3
CityOSLO
PostcodeNO-0213
CountryNorway
Phone number (incl. country code)
Alternative phone number
Fax number (incl. country code)
2. Description
The Research Unit at the Dept Chronic Diseases and Ageing, at the Norwegian Institute of Public Health (NIPH) is the largest pharmacoepi research entity in Norway with 7 fulltime research scientists. We have long experience in using Norwegian and Nordic high-quality population-based health registers in our research. NIPH run the Norwegian Prescription Database (NorPD), a nationwide prescription database and also has other nationwide health registries in-house, i.e. the Norwegian Medical Birth Registry, Cause of death registry and large population-based health surveys.
3. Category
Government based
Public research institute
4. Available resources
In houseVia Contacts/Network
5. Therapeutic/disease areas of research in drug safety/risk-benefit performed in the past 5 years
Cardiovascular diseases
Congenital Malformations
Disorders of the central nervous system
Immunological products and vaccines
Malignant disease
Osteoporosis
Pregnancy
Respiratory diseases
6. Design of drug safety/risk-benefit studies published in the past 5 years
Cohort Study
Drug Utilisation
7. Experience in collecting data directly from individual patients/respondents
None
8. Access to data collection resources
Capacity to conduct face-to-face interviews
No
Electronic data capture systems
No
Interactive voice response systems
No
Call centre
No
9. Experience in secondary research and meta-analysis
No
10. Work with existing data resources in the past 3 years
Name of data resourceNo. of studies
NorPD30
Danish Medical Registries5
The Swedish prescribed drug register8
Icelandic National Registries5
Drugs and Pregnancy Finland5
11. Registries established by centre
Drug RegistryNorPD, all drug classes, nationwide prescription database
Disease RegistryNorwegian Heart diseases
Other Norwegian Medical Birth registry
12. Experience in collaboration in a study team
Principal Investigator
Collaborating Investigator
13. Current involvement in research networks
Networks registered with ENCePP
EUROCAT
EuroDURG
Other networks:
Network nameNationalInternationalLink to webpage
14. Interest in research opportunities which are funded
By government
By research councils
By EU funding schemes
15. Interest in contract research only if free to publish results
Yes
16. Selected publications of the last 5 calendar years
ReferenceLink to web-publication
Engeland A,Bjørge T, Klungsøyr K, Hjellvik V, Skurtveit S, Furu K. Trends in prescription drug use during pregnancy and postpartum in Norway, 2005-2015. Pharmacoepidemiol Drug Saf 2018; 27:995-1004
Huybrechts, KF; Bröms, G; Christensen, LB; Einarsdottir, K; Engeland, A; Furu, K; Gissler, M; Hernandez-Diaz, S; Karlsson, P; Karlstad, Ø; Kieler, H; Lahesmaa-Korpinen, AM; Mogun, H; Nørgaard, M; Reutfors, J; Sørensen, HT; Zoega, H; Bateman, BT. Association between Methylphenidate and Amphetamine use in Pregnancy and Risk of Congenital Malformations: A cohort study from the International Pregnancy Safety Study (InPreSS) Consortium. JAMA Psychiatry 2018;75(2).167-75. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2664964
